FRX.TO
Companies
Toronto Stock Exchange
Fennec Pharmaceuticals Inc.
Health Care
$7.78
+$1.62 (+26.24%)
Price Chart
Overview
About FRX.TO
fennec pharmaceuticals inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the united states. its lead product pedmark, a formulation of sodium thiosulfate, which has completed the phase iii clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. the company was formerly known as adherex technologies inc. and changed its name to fennec pharmaceuticals inc. in september 2014. fennec pharmaceuticals inc. was founded in 1996 and is based in research triangle park, north carolina.
Market Cap
$260.7M
Volume
5.0K
Avg. Volume
2.3K
P/E Ratio
10.695187165775401
Dividend Yield
0.00%
Employees
30.0
Company Information
Exchange
Toronto Stock Exchange
Sector
Health Care
Industry
Biotechnology
Latest News for FRX.TO
Risk & Correlation Analysis
Market Correlation
0.48
Low Correlation
Volatility
High (0.65)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, FRX.TO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025